BioCentury
ARTICLE | Clinical News

CHX-100: Filed IND to begin a Phase II trial

October 4, 1993 7:00 AM UTC

Chemex Pharmaceuticals Inc. (CHMX) Product: CHX-100, masoprocol cream Indication: Anti-wrinkling agent Status: Filed IND to begin a Phase II trial Note: CHMX believes the FDA will allow Phase II trial...